IAN TUCKER: Open Payments
NPI 1538130836 · ENFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,329 in 68 payments from 26 companies in 2025. Trend: 2023 $222 · 2024 $515 · 2025 $1,329
Food & beverage: $1,329
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $237 |
| AstraZeneca Pharmaceuticals LP | 6 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $104 |
| Lilly USA, LLC | 4 | $91 |
| Novo Nordisk Inc | 4 | $80 |
| PFIZER INC. | 4 | $69 |
| GlaxoSmithKline, LLC. | 3 | $69 |
| Exact Sciences Corporation | 3 | $67 |
| Amneal Pharmaceuticals LLC | 3 | $46 |
| Actelion Pharmaceuticals US, Inc. | 2 | $39 |
Products named: VRAYLAR, AIRSUPRA, CAPLYTA, PREVNAR 20, The Cologuard Plus Collection Kit, TRELEGY ELLIPTA, ZEPBOUND, UNITHROID.
Industry payments across CT — which companies pay providers there.
